tiprankstipranks
Sienna Biopharmaceuticals (SNNAQ)
OTHER OTC:SNNAQ
US Market
Holding SNNAQ?
Track your performance easily

Sienna Biopharmaceuticals (SNNAQ) Financial Statements

70 Followers

Sienna Biopharmaceuticals Financial Overview

Sienna Biopharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Sienna Biopharmaceuticals is scheduled to report earnings on October 9, 2020, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 19Jun 19Mar 19Dec 18Sep 18
Income Statement-
Total Revenue$ 27.00K$ 27.00K$ 9.00K--
Gross Profit$ 27.00K$ 27.00K$ 9.00K--
EBIT$ -6.58M$ -8.26M$ -16.38M$ -19.81M$ -16.79M
EBITDA$ -6.35M$ -7.99M$ -16.11M$ -19.64M$ -16.63M
Net Income Common Stockholders$ -3.97M$ -8.26M$ -16.38M$ -19.34M$ -16.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 11.54M$ 49.39M$ 57.35M$ 48.71M$ 64.16M
Total Assets$ 43.49M$ 107.63M$ 115.05M$ 107.31M$ 124.63M
Total Debt$ 0.00$ 30.02M$ 29.82M$ 30.13M$ 29.98M
Net Debt$ -11.54M$ -19.37M$ -27.53M$ -18.58M$ -34.17M
Total Liabilities$ 20.39M$ 80.64M$ 81.77M$ 80.72M$ 79.70M
Stockholders Equity$ 23.10M$ 26.98M$ 33.29M$ 26.58M$ 44.93M
Cash Flow-
Free Cash Flow$ 15.66M$ -8.12M$ -17.37M$ -20.30M$ -15.21M
Operating Cash Flow$ 15.66M$ -8.12M$ -17.37M$ -20.30M$ -15.19M
Investing Cash Flow$ -33.50M$ -300.00K$ 4.60M$ 4.69M$ -716.00K
Financing Cash Flow$ -20.00M$ 452.00K$ 21.43M$ 293.00K$ 4.99M
Currency in USD

Sienna Biopharmaceuticals Earnings and Revenue History

Sienna Biopharmaceuticals Debt to Assets

Sienna Biopharmaceuticals Cash Flow

Sienna Biopharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis